3-[3-(3-chlorophenyl)propyl]-5-[[(1R,2R)-2-[(E,1S)-1-methoxy-6-sulfanylhex-2-enyl]cyclobutyl]methyl]-3,4-dihydro-2H-1,5-benzoxazepine-7-carboxamide

C31H41ClN2O3S — CID 153364309

IUPAC3-[3-(3-chlorophenyl)propyl]-5-[[(1R,2R)-2-[(E,1S)-1-methoxy-6-sulfanylhex-2-enyl]cyclobutyl]methyl]-3,4-dihydro-2H-1,5-benzoxazepine-7-carboxamide
SMILESCO[C@@H](/C=C/CCCS)[C@@H]1CC[C@H]1CN1CC(CCCc2cccc(Cl)c2)COc2ccc(C(N)=O)cc21
InChIInChI=1S/C31H41ClN2O3S/c1-36-29(11-3-2-4-16-38)27-14-12-25(27)20-34-19-23(9-5-7-22-8-6-10-26(32)17-22)21-37-30-15-13-24(31(33)35)18-28(30)34/h3,6,8,10-11,13,15,17-18,23,25,27,29,38H,2,4-5,7,9,12,14,16,19-21H2,1H3,(H2,33,35)/b11-3+/t23?,25-,27+,29-/m0/s1
InChIKeyRHVRGAJYFUWVOT-FMRHZVQOSA-N
MW557.20 g/mol
LogP6.58
Rot. Bonds13

About 3-[3-(3-chlorophenyl)propyl]-5-[[(1R,2R)-2-[(E,1S)-1-methoxy-6-sulfanylhex-2-enyl]cyclobutyl]methyl]-3,4-dihydro-2H-1,5-benzoxazepine-7-carboxamide

3-[3-(3-chlorophenyl)propyl]-5-[[(1R,2R)-2-[(E,1S)-1-methoxy-6-sulfanylhex-2-enyl]cyclobutyl]methyl]-3,4-dihydro-2H-1,5-benzoxazepine-7-carboxamide (PubChem CID 153364309) has the molecular formula C31H41ClN2O3S and a molecular weight of 557.20 g/mol. Its IUPAC name is 3-[3-(3-chlorophenyl)propyl]-5-[[(1R,2R)-2-[(E,1S)-1-methoxy-6-sulfanylhex-2-enyl]cyclobutyl]methyl]-3,4-dihydro-2H-1,5-benzoxazepine-7-carboxamide.

Molecular Properties

Compound Name3-[3-(3-chlorophenyl)propyl]-5-[[(1R,2R)-2-[(E,1S)-1-methoxy-6-sulfanylhex-2-enyl]cyclobutyl]methyl]-3,4-dihydro-2H-1,5-benzoxazepine-7-carboxamide
PubChem CID153364309
Molecular FormulaC31H41ClN2O3S
Molecular Weight557.20 g/mol
Exact Mass556.25
IUPAC Name3-[3-(3-chlorophenyl)propyl]-5-[[(1R,2R)-2-[(E,1S)-1-methoxy-6-sulfanylhex-2-enyl]cyclobutyl]methyl]-3,4-dihydro-2H-1,5-benzoxazepine-7-carboxamide
SMILESCO[C@@H](/C=C/CCCS)[C@@H]1CC[C@H]1CN1CC(CCCc2cccc(Cl)c2)COc2ccc(C(N)=O)cc21
InChIInChI=1S/C31H41ClN2O3S/c1-36-29(11-3-2-4-16-38)27-14-12-25(27)20-34-19-23(9-5-7-22-8-6-10-26(32)17-22)21-37-30-15-13-24(31(33)35)18-28(30)34/h3,6,8,10-11,13,15,17-18,23,25,27,29,38H,2,4-5,7,9,12,14,16,19-21H2,1H3,(H2,33,35)/b11-3+/t23?,25-,27+,29-/m0/s1
InChIKeyRHVRGAJYFUWVOT-FMRHZVQOSA-N
XLogP6.58
TPSA64.79 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds13
Heavy Atoms38
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500557.20
LogP ≤ 56.58
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'thiol_2', 'substructure': 'N/A'}

Analyze 3-[3-(3-chlorophenyl)propyl]-5-[[(1R,2R)-2-[(E,1S)-1-methoxy-6-sulfanylhex-2-enyl]cyclobutyl]methyl]-3,4-dihydro-2H-1,5-benzoxazepine-7-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[3-(3-chlorophenyl)propyl]-5-[[(1R,2R)-2-[(E,1S)-1-methoxy-6-sulfanylhex-2-enyl]cyclobutyl]methyl]-3,4-dihydro-2H-1,5-benzoxazepine-7-carboxamide?
The IUPAC name of 3-[3-(3-chlorophenyl)propyl]-5-[[(1R,2R)-2-[(E,1S)-1-methoxy-6-sulfanylhex-2-enyl]cyclobutyl]methyl]-3,4-dihydro-2H-1,5-benzoxazepine-7-carboxamide (CID 153364309) is 3-[3-(3-chlorophenyl)propyl]-5-[[(1R,2R)-2-[(E,1S)-1-methoxy-6-sulfanylhex-2-enyl]cyclobutyl]methyl]-3,4-dihydro-2H-1,5-benzoxazepine-7-carboxamide.
What is the SMILES notation for 3-[3-(3-chlorophenyl)propyl]-5-[[(1R,2R)-2-[(E,1S)-1-methoxy-6-sulfanylhex-2-enyl]cyclobutyl]methyl]-3,4-dihydro-2H-1,5-benzoxazepine-7-carboxamide?
The canonical SMILES for 3-[3-(3-chlorophenyl)propyl]-5-[[(1R,2R)-2-[(E,1S)-1-methoxy-6-sulfanylhex-2-enyl]cyclobutyl]methyl]-3,4-dihydro-2H-1,5-benzoxazepine-7-carboxamide is CO[C@@H](/C=C/CCCS)[C@@H]1CC[C@H]1CN1CC(CCCc2cccc(Cl)c2)COc2ccc(C(N)=O)cc21.
What is the InChIKey of 3-[3-(3-chlorophenyl)propyl]-5-[[(1R,2R)-2-[(E,1S)-1-methoxy-6-sulfanylhex-2-enyl]cyclobutyl]methyl]-3,4-dihydro-2H-1,5-benzoxazepine-7-carboxamide?
The InChIKey is RHVRGAJYFUWVOT-FMRHZVQOSA-N. The full InChI is InChI=1S/C31H41ClN2O3S/c1-36-29(11-3-2-4-16-38)27-14-12-25(27)20-34-19-23(9-5-7-22-8-6-10-26(32)17-22)21-37-30-15-13-24(31(33)35)18-28(30)34/h3,6,8,10-11,13,15,17-18,23,25,27,29,38H,2,4-5,7,9,12,14,16,19-21H2,1H3,(H2,33,35)/b11-3+/t23?,25-,27+,29-/m0/s1.
What are the key properties of 3-[3-(3-chlorophenyl)propyl]-5-[[(1R,2R)-2-[(E,1S)-1-methoxy-6-sulfanylhex-2-enyl]cyclobutyl]methyl]-3,4-dihydro-2H-1,5-benzoxazepine-7-carboxamide?
3-[3-(3-chlorophenyl)propyl]-5-[[(1R,2R)-2-[(E,1S)-1-methoxy-6-sulfanylhex-2-enyl]cyclobutyl]methyl]-3,4-dihydro-2H-1,5-benzoxazepine-7-carboxamide has a molecular weight of 557.20 g/mol, XLogP of 6.58, 13 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[3-(3-chlorophenyl)propyl]-5-[[(1R,2R)-2-[(E,1S)-1-methoxy-6-sulfanylhex-2-enyl]cyclobutyl]methyl]-3,4-dihydro-2H-1,5-benzoxazepine-7-carboxamide is sourced from PubChem (CID 153364309), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).